{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:28:54Z","timestamp":1790764134756,"version":"4.1.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lfs.2024.122743","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T14:02:21Z","timestamp":1716732141000},"page":"122743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma"],"prefix":"10.1016","volume":"350","author":[{"given":"S.N.","family":"Mousavikia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Darvish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Bahreyni Toossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Azimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0005","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W","article-title":"Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas","volume":"79","author":"Coons","year":"1997","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.lfs.2024.122743_bb0010","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.3390\/ijms222212608","article-title":"Hypoxia: the cornerstone of glioblastoma","volume":"22","author":"Dom\u00e8nech","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"32","key":"10.1016\/j.lfs.2024.122743_bb0015","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2013.49.6968","article-title":"Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial","volume":"31","author":"Gilbert","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/pr.117.014944","article-title":"Current challenges and opportunities in treating glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/BST20180444","article-title":"Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments","volume":"47","author":"Perrin","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.lfs.2024.122743_bb0030","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.2147\/OTT.S260376","article-title":"Emerging roles and therapeutic interventions of aerobic glycolysis in glioma","author":"Han","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.lfs.2024.122743_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0040","first-page":"240","article-title":"TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma","volume":"22","author":"Fu","year":"2020","journal-title":"Neuro-Oncology."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0045","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","article-title":"Blood\u2013brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy","volume":"10","author":"Galstyan","year":"2019","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0050","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1158\/0008-5472.CAN-11-0153","article-title":"Heterogeneity maintenance in glioblastoma: a social network","volume":"71","author":"Bonavia","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jnci\/djq497","article-title":"DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma","volume":"103","author":"Christensen","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2024.122743_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624725","article-title":"Tumor immune microenvironment and its related miRNAs in tumor progression","volume":"12","author":"Xing","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122743_bb0065","series-title":"Seminars in Cancer Biology","article-title":"Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology","year":"2021"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7150\/ijbs.53671","article-title":"Regulation of exosome production and cargo sorting","volume":"17","author":"Wei","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2024.122743_bb0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcell.2016.00084","article-title":"Biogenesis and function of T cell-derived exosomes","volume":"4","author":"Ventimiglia","year":"2016","journal-title":"Frontiers in Cell and Developmental Biology."},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0080","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2019-0116","article-title":"Role of exosomes and exosomal microRNAs in cancer","volume":"6","author":"Dilsiz","year":"2020","journal-title":"Future Sci. OA"},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/cells8040307","article-title":"Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes","volume":"8","author":"Gurunathan","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00987-y","article-title":"Isolation and characterization of exosomes for cancer research","volume":"13","author":"Zhu","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.lfs.2024.122743_bb0095","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cbin.11620","article-title":"Exosomes: isolation, characterization, and biomedical applications","volume":"45","author":"Alzhrani","year":"2021","journal-title":"Cell Biol. Int."},{"issue":"10","key":"10.1016\/j.lfs.2024.122743_bb0100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.4155\/fmc-2018-0417","article-title":"Exosome manufacturing status","volume":"11","author":"Whitford","year":"2019","journal-title":"Future Med. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2024.122743_bb0105","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-05-4579","article-title":"The regulation of exosome secretion: a novel function of the p53 protein","volume":"66","author":"Yu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.122743_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ceb.2014.05.004","article-title":"Biogenesis and secretion of exosomes","volume":"29","author":"Kowal","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"issue":"11","key":"10.1016\/j.lfs.2024.122743_bb0115","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","article-title":"Exosomes nature's lipid nanoparticles, a rising star in drug delivery and diagnostics","volume":"16","author":"Tenchov","year":"2022","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1194\/jlr.R084343","article-title":"Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology","volume":"60","author":"Skotland","year":"2019","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in exosome isolation techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2024.122743_bb0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fonc.2018.00066","article-title":"The origin and functions of exosomes in cancer","volume":"8","author":"Rajagopal","year":"2018","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0135","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1039\/C7AN00672A","article-title":"Quantum dot-based sensitive detection of disease specific exosome in serum","volume":"142","author":"Boriachek","year":"2017","journal-title":"Analyst"},{"issue":"6","key":"10.1016\/j.lfs.2024.122743_bb0140","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.3892\/mmr.2015.3312","article-title":"Intercellular transfer of messenger RNAs in multiorgan tumorigenesis by tumor cell-derived exosomes","volume":"11","author":"Jiang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0145","doi-asserted-by":"crossref","first-page":"27031","DOI":"10.3402\/jev.v4.27031","article-title":"Optimized exosome isolation protocol for cell culture supernatant and human plasma","volume":"4","author":"Lobb","year":"2015","journal-title":"Journal of Extracellular Vesicles."},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5213\/inj.1734961.458","article-title":"Extracellular vesicles as a source of urological biomarkers: lessons learned from advances and challenges in clinical applications to major diseases","volume":"21","author":"Choi","year":"2017","journal-title":"Int. Neurourol. J."},{"key":"10.1016\/j.lfs.2024.122743_bb0155","unstructured":"Nordin JZ, Lee Y, Vader P, M\u00e4ger I, Johansson HJ, H\u00e4llbrink M, et al. Ultrafiltration with size-exclusion liquid chromatography for high yield."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1667\/RADE-20-00019.1","article-title":"Radiation-induced bystander effect can be transmitted through exosomes using miRNAs as effector molecules","volume":"194","author":"Du","year":"2020","journal-title":"Radiat. Res."},{"key":"10.1016\/j.lfs.2024.122743_bb0165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10103-019-02880-8","article-title":"Tumor-derived extracellular vesicles: insights into bystander effects of exosomes after irradiation","volume":"35","author":"Jabbari","year":"2020","journal-title":"Lasers Med. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0170","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41416-018-0192-9","article-title":"Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4","volume":"119","author":"Mo","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005219","article-title":"High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients","volume":"4","author":"Logozzi","year":"2009","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0180","doi-asserted-by":"crossref","first-page":"27575","DOI":"10.3402\/jev.v4.27575","article-title":"Potential functional applications of extracellular vesicles: a report by the NIH common fund extracellular RNA communication consortium","volume":"4","author":"Quesenberry","year":"2015","journal-title":"Journal of Extracellular Vesicles."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","article-title":"Mesenchymal stem cells current clinical applications: a systematic review","volume":"52","author":"Rodr\u00edguez-Fuentes","year":"2021","journal-title":"Arch. Med. Res."},{"issue":"9","key":"10.1016\/j.lfs.2024.122743_bb0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0195","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/cells10030512","article-title":"Role of tumor-derived extracellular vesicles in glioblastoma","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0205","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/acs.jproteome.3c00614","article-title":"In-depth proteome profiling of small extracellular vesicles isolated from cancer cell lines and patient serum","volume":"23","author":"Abhange","year":"2023","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","article-title":"Exosome-based liquid biopsies in cancer: opportunities and challenges","volume":"32","author":"Yu","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lfs.2024.122743_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jocn.2016.09.021","article-title":"The emergent role of exosomes in glioma","volume":"35","author":"Gourlay","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.lfs.2024.122743_bb0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11060-015-1984-x","article-title":"ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation","volume":"126","author":"Xu","year":"2016","journal-title":"J. Neurooncol"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11011-022-01074-6","article-title":"Emerging role of extracellular vesicles in the pathogenesis of glioblastoma","volume":"38","author":"Khayamzadeh","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.lfs.2024.122743_bb0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fmed.2020.00028","article-title":"Peripheral blood-based biopsy for breast cancer risk prediction and early detection","volume":"7","author":"Nassar","year":"2020","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.lfs.2024.122743_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160722","article-title":"Diagnostic potential of cell-free and exosomal microRNAs in the identification of patients with high-risk colorectal adenomas","volume":"11","author":"Uratani","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2024.122743_bb0240","article-title":"microRNAs: potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways","volume":"816","author":"Bahreyni-Toossi","year":"2019","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis."},{"key":"10.1016\/j.lfs.2024.122743_bb0245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-015-1784-3","article-title":"miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients","volume":"123","author":"Akers","year":"2015","journal-title":"J. Neurooncol"},{"issue":"5","key":"10.1016\/j.lfs.2024.122743_bb0250","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1389202916666150707155610","article-title":"miR-15b and miR-21 as circulating biomarkers for diagnosis of glioma","volume":"16","author":"Ivo D\u2019Urso","year":"2015","journal-title":"Curr. Genomics"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nor169","article-title":"Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma","volume":"14","author":"Baraniskin","year":"2012","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.lfs.2024.122743_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110580","article-title":"The role of microRNA-induced apoptosis in diverse radioresistant cancers","volume":"104","author":"Darvish","year":"2023","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.lfs.2024.122743_bb0265","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1074\/jbc.M116.772392","article-title":"miR-21-mediated radioresistance occurs via promoting repair of DNA double strand breaks","volume":"292","author":"Hu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122743_bb0270","series-title":"Silencing of microRNA-21 Confers Radio-Sensitivity through Inhibition of the PI3K\/AKT Pathway and Enhancing Autophagy in Malignant Glioma Cell Lines","author":"Gwak","year":"2012"},{"issue":"10","key":"10.1016\/j.lfs.2024.122743_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047449","article-title":"Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K\/AKT pathway and enhancing autophagy in malignant glioma cell lines","volume":"7","author":"Gwak","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2024.122743_bb0280","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12031-012-9759-8","article-title":"MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide","volume":"47","author":"Zhang","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2024.122743_bb0285","article-title":"Inducing apoptosis by using microRNA in radio-resistant prostate cancer: an in-silico study with an in-vitro validation","volume":"1-12","author":"Darvish","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0290","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/neuonc\/not218","article-title":"A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool","volume":"16","author":"Manterola","year":"2014","journal-title":"Neuro-oncology."},{"issue":"6","key":"10.1016\/j.lfs.2024.122743_bb0295","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.3892\/mmr.2017.7770","article-title":"Potential lncRNA diagnostic biomarkers for early gastric cancer","volume":"16","author":"Lu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2024.122743_bb0300","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07649-9","article-title":"Long non-coding RNA SNHG15 in various cancers: a meta and bioinformatic analysis","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0310","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3892\/or.2012.2219","article-title":"Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma","volume":"29","author":"Ishibashi","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2024.122743_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-018-0822-0","article-title":"Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme","volume":"17","author":"Tan","year":"2018","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0320","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/jcp.25739","article-title":"Diagnostic and therapeutic potential of exosomes in cancer: the beginning of a new tale?","volume":"232","author":"Mirzaei","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0325","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/biomedicines8070216","article-title":"Proteome of glioblastoma-derived exosomes as a source of biomarkers","volume":"8","author":"Naryzhny","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.122743_bb0330","series-title":"Proceedings of the First Asia-Pacific Bioinformatics Conference on Bioinformatics 2003","article-title":"Machine learning in DNA microarray analysis for cancer classification","volume":"Volume 19","year":"2003"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0335","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1038\/s41598-022-12566-x","article-title":"Machine learning and bioinformatics approaches for classification and clinical detection of bevacizumab responsive glioblastoma subtypes based on miRNA expression","volume":"12","author":"Shi","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0340","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/metabo10030088","article-title":"Analysis and simulation of glioblastoma cell lines-derived extracellular vesicles metabolome","volume":"10","author":"\u010cuperlovi\u0107-Culf","year":"2020","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.lfs.2024.122743_bb0345","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/neuonc\/nos074","article-title":"MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity","volume":"14","author":"Teplyuk","year":"2012","journal-title":"Neuro-oncology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2024.122743_bb0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jns.2014.11.036","article-title":"Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles","volume":"348","author":"Qu","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lfs.2024.122743_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101451","article-title":"Targeting miR-9 in glioma stem cell-derived extracellular vesicles: a novel diagnostic and therapeutic biomarker","volume":"22","author":"Geng","year":"2022","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/biomedicines10010112","article-title":"The activation of mesenchymal stem cells by glioblastoma microvesicles alters their exosomal secretion of miR-100-5p, miR-9-5p and let-7d-5p","volume":"10","author":"Garnier","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.122743_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1078-2","article-title":"MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma","volume":"38","author":"Chen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122743_bb0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-019-03275-z","article-title":"MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway","volume":"145","author":"Yang","year":"2019","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.lfs.2024.122743_bb0375","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12031-018-1177-0","article-title":"MiR-29a-mediated CD133 expression contributes to cisplatin resistance in CD133+ glioblastoma stem cells","volume":"66","author":"Yang","year":"2018","journal-title":"J. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0380","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/bjc.2017.255","article-title":"miR-29a\/b\/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients","volume":"117","author":"Shi","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2024.122743_bb0385","first-page":"2018","article-title":"MiR-29a inhibits glioma tumorigenesis through a negative feedback loop of TRAF4\/Akt signaling","author":"Liu","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0390","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/ijc.32052","article-title":"Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a\/Hbp1 and microRNA-92a\/Prkar1a pathways","volume":"144","author":"Guo","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0395","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jocn.2012.10.015","article-title":"Identification of microRNA-205 as a potential prognostic indicator for human glioma","volume":"20","author":"Hou","year":"2013","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0400","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3171\/2015.1.JNS141577","article-title":"Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma","volume":"124","author":"Yue","year":"2016","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0405","first-page":"485","article-title":"Downregulation of miR-205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt\/mTOR signaling pathway","volume":"52","author":"Chen","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122743_bb0410","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jnutbio.2014.11.015","article-title":"Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78\/miR-205 axis","volume":"26","author":"Huynh","year":"2015","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0415","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/CBM-181416","article-title":"Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients","volume":"24","author":"Zhang","year":"2019","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.lfs.2024.122743_bb0420","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820960748","article-title":"MicroRNA miR-100 decreases glioblastoma growth by targeting SMARCA5 and ErbB3 in tumor-initiating cells","volume":"19","author":"Alrfaei","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.lfs.2024.122743_bb0425","first-page":"3391","article-title":"Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3","author":"Luan","year":"2015","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.lfs.2024.122743_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105652","article-title":"Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas","volume":"190","author":"Tabibkhooei","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0435","first-page":"1967","article-title":"Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma","volume":"19","author":"Lan","year":"2020","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0440","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7150\/jca.10765","article-title":"MicroRNA-210 and endoplasmic reticulum chaperones in the regulation of chemoresistance in glioblastoma","volume":"6","author":"Lee","year":"2015","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-229","article-title":"MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma","volume":"9","author":"Zhang","year":"2010","journal-title":"Mol. Cancer"},{"issue":"33","key":"10.1016\/j.lfs.2024.122743_bb0450","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1038\/s41388-019-0867-6","article-title":"Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma","volume":"38","author":"Sun","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.lfs.2024.122743_bb0455","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jat.3762","article-title":"miR-222\/GAS5 is involved in DNA damage and cytotoxic effects induced by temozolomide in T98G cell line","volume":"39","author":"Huang","year":"2019","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0460","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/1566524013666131203103147","article-title":"miR-221\/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status","volume":"14","author":"Li","year":"2014","journal-title":"Curr. Mol. Med."},{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0465","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/onc.2011.280","article-title":"miR-221\/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTP\u03bc","volume":"31","author":"Quintavalle","year":"2012","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.lfs.2024.122743_bb0470","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1093\/nar\/gkr006","article-title":"NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells","volume":"39","author":"Galardi","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2024.122743_bb0475","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11060-019-03256-2","article-title":"Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform","volume":"144","author":"Swellam","year":"2019","journal-title":"J. Neurooncol"},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0480","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3390\/cancers13123006","article-title":"Serum exosomal microRNA-21, 222 and 124-3p as noninvasive predictive biomarkers in newly diagnosed high-grade gliomas: a prospective study","volume":"13","author":"Olioso","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0485","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/mc.23617","article-title":"Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA\/miR221-3p\/222-3p axis in glioblastoma","volume":"62","author":"Malik","year":"2023","journal-title":"Mol. Carcinog"},{"key":"10.1016\/j.lfs.2024.122743_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-6-29","article-title":"MicroRNA expression profiles in human cancer cells after ionizing radiation","volume":"6","author":"Niemoeller","year":"2011","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lfs.2024.122743_bb0495","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2018.08.004","article-title":"Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma","volume":"436","author":"Zeng","year":"2018","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0500","first-page":"997","article-title":"MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2","volume":"23","author":"Chen","year":"2010","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0505","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.3390\/cancers12123813","article-title":"MiR-181 family modulates osteopontin in glioblastoma multiforme","volume":"12","author":"Marisetty","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0510","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1080\/13813455.2020.1739716","article-title":"Relevance of circulating MiRNA-21 and MiRNA-181 in prediction of glioblastoma multiforme prognosis","volume":"128","author":"Labib","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"issue":"35","key":"10.1016\/j.lfs.2024.122743_bb0515","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/onc.2017.129","article-title":"MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.lfs.2024.122743_bb0520","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.3390\/ijms21207450","article-title":"Unique interplay between molecular miR-181b\/d biomarkers and health related quality of life score in the predictive glioma models","volume":"21","author":"Stakaitis","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122743_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-016-0393-0","article-title":"A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas","volume":"35","author":"Regazzo","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0530","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.7150\/jca.62652","article-title":"miR-497-5p-RSPO2 axis inhibits cell growth and metastasis in glioblastoma","volume":"13","author":"Chen","year":"2022","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0535","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/cam4.987","article-title":"Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR\/Bcl-2","volume":"6","author":"Zhu","year":"2017","journal-title":"Cancer Med."},{"issue":"18","key":"10.1016\/j.lfs.2024.122743_bb0540","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/j.febslet.2014.07.021","article-title":"Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis","volume":"588","author":"Lan","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2024.122743_bb0545","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2016.04.022","article-title":"Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas","volume":"58","author":"Feng","year":"2016","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0550","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/hmg\/ddt437","article-title":"Tumor-derived exosomes are enriched in \u0394Np73, which promotes oncogenic potential in acceptor cells and correlates with patient survival","volume":"23","author":"Soldevilla","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0555","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0560","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1078-0432.CCR-17-0605","article-title":"Long noncoding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT\/\u03b2-catenin pathway by scaffolding EZH2","volume":"24","author":"Chen","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0565","first-page":"713","article-title":"Exosomal lncRNA-ATB activates astrocytes that promote glioma cell invasion","volume":"54","author":"Bian","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0570","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41467-019-10025-2","article-title":"Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-met pathway by competitively binding with miR-20b-3p","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0575","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.lfs.2024.122743_bb0580","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"30","key":"10.1016\/j.lfs.2024.122743_bb0585","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.0804273106","article-title":"Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion","volume":"106","author":"Markovic","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"22","key":"10.1016\/j.lfs.2024.122743_bb0590","article-title":"C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1\/2 signaling pathway","volume":"22","author":"Liu","year":"2018","journal-title":"European Review for Medical & Pharmacological Sciences."},{"issue":"45","key":"10.1016\/j.lfs.2024.122743_bb0595","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2024.122743_bb0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0975-5","article-title":"Exosomes in the tumor microenvironment as mediators of cancer therapy resistance","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"issue":"29","key":"10.1016\/j.lfs.2024.122743_bb0605","doi-asserted-by":"crossref","first-page":"24821","DOI":"10.1074\/jbc.M111.334540","article-title":"Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation","volume":"287","author":"Francescone","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0610","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122743_bb0615","article-title":"Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3","volume":"21","author":"Lang","year":"2017","journal-title":"European Review for Medical & Pharmacological Sciences."},{"key":"10.1016\/j.lfs.2024.122743_bb0620","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10456-011-9241-1","article-title":"Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion","volume":"15","author":"Mineo","year":"2012","journal-title":"Angiogenesis"},{"issue":"11","key":"10.1016\/j.lfs.2024.122743_bb0625","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/labinvest.2009.94","article-title":"Paracrine induction of endothelium by tumor exosomes","volume":"89","author":"Hood","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.lfs.2024.122743_bb0630","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.3627","article-title":"The extracellular vesicles secreted by lung cancer cells in radiation therapy promote endothelial cell angiogenesis by transferring miR-23a","volume":"5","author":"Zheng","year":"2017","journal-title":"PeerJ"},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0635","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41419-023-05663-w","article-title":"Glioblastoma upregulates SUMOylation of hnRNP A2\/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia","volume":"14","author":"Guo","year":"2023","journal-title":"Cell Death Dis."},{"issue":"22","key":"10.1016\/j.lfs.2024.122743_bb0640","doi-asserted-by":"crossref","first-page":"36137","DOI":"10.18632\/oncotarget.16661","article-title":"Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21\/VEGF signal","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01566-4","article-title":"Glioma exosomal microRNA-148a-3p promotes tumor angiogenesis through activating the EGFR\/MAPK signaling pathway via inhibiting ERRFI1","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.lfs.2024.122743_bb0650","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1541-7786.MCR-19-0725","article-title":"Hypoxic cancer-secreted exosomal miR-182-5p promotes glioblastoma angiogenesis by targeting Kruppel-like factor 2 and 4","volume":"18","author":"Li","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122743_bb0655","first-page":"1","article-title":"Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.lfs.2024.122743_bb0660","doi-asserted-by":"crossref","first-page":"19243","DOI":"10.18632\/aging.203243","article-title":"Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT\/ERK signaling","volume":"13","author":"Jiang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02426-5","article-title":"Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications","volume":"18","author":"Ahmadi","year":"2020","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0670","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.7150\/ijms.71912","article-title":"Exosomes derived from glioma cells under hypoxia promote angiogenesis through up-regulated exosomal connexin 43","volume":"19","author":"Yang","year":"2022","journal-title":"Int. J. Med. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2024.122743_bb0675","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1158\/1541-7786.MCR-18-0358","article-title":"Exosomes from HNSCC promote angiogenesis through reprogramming of endothelial cells","volume":"16","author":"Ludwig","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lfs.2024.122743_bb0680","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1007\/s13277-016-5165-0","article-title":"From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis","volume":"37","author":"Giusti","year":"2016","journal-title":"Tumour Biol."},{"issue":"11","key":"10.1016\/j.lfs.2024.122743_bb0685","first-page":"1737","article-title":"Effect of acute and chronic toxicity of paraquat on immune system and growth performance in rainbow trout, O ncorhynchus mykiss","volume":"45","author":"Tukmechi","year":"2014","journal-title":"Aquaculture Research"},{"issue":"5","key":"10.1016\/j.lfs.2024.122743_bb0690","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.nano.2017.03.001","article-title":"Milk-derived exosomes for oral delivery of paclitaxel","volume":"13","author":"Agrawal","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.lfs.2024.122743_bb0695","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2024.122743_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216077","article-title":"Exosomes; multifaceted nanoplatform for targeting brain cancers","volume":"557","author":"Mardi","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2024.122743_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121367","article-title":"Therapeutic nanoparticles in the brain: A review of types, physicochemical properties and challenges","volume":"612","author":"de Lima","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.lfs.2024.122743_bb0710","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.3390\/ijms23084153","article-title":"Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122743_bb0715","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10311-018-00841-1","article-title":"Nanocarriers for drug delivery applications","volume":"17","author":"Chamundeeswari","year":"2019","journal-title":"Environ. Chem. Lett."},{"key":"10.1016\/j.lfs.2024.122743_bb0720","article-title":"Exosomes: from garbage bins to promising therapeutic targets","volume":"18(3):538","author":"Rashed","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0725","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","author":"Gregory","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.122743_bb0730","article-title":"Exosomes: promising delivery tools for overcoming blood-brain barrier and glioblastoma therapy","volume":"1-20","author":"Khatami","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2024.122743_bb0735","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jconrel.2020.10.020","article-title":"Challenges in the development and establishment of exosome-based drug delivery systems","volume":"329","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.lfs.2024.122743_bb0740","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.brainresbull.2007.10.043","article-title":"Functional and developmental analysis of the blood\u2013brain barrier in zebrafish","volume":"75","author":"Jeong","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2024.122743_bb0745","doi-asserted-by":"crossref","first-page":"1101522","DOI":"10.3389\/fonc.2023.1101522","article-title":"Addressing blood-brain-tumor-barrier heterogeneity in pediatric brain tumors with innovative preclinical models","volume":"13","author":"Morris","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2024.122743_bb0750","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1208\/s12248-016-0015-y","article-title":"Delivery of small interfering RNA to inhibit vascular endothelial growth factor in zebrafish using natural brain endothelia cell-secreted exosome nanovesicles for the treatment of brain cancer","volume":"19","author":"Yang","year":"2017","journal-title":"AAPS J."},{"issue":"8","key":"10.1016\/j.lfs.2024.122743_bb0755","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI84577","article-title":"Donor dendritic cell\u2013derived exosomes promote allograft-targeting immune response","volume":"126","author":"Liu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122743_bb0760","series-title":"Seminars in Cell & Developmental Biology","article-title":"Mesenchymal stem cell exosomes","year":"2015"},{"key":"10.1016\/j.lfs.2024.122743_bb0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.12.005","article-title":"Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis","volume":"318","author":"Zhao","year":"2020","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.lfs.2024.122743_bb0770","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.5114\/aoms.2016.62911","article-title":"Exosomes as nanocarriers for siRNA delivery: paradigms and challenges","volume":"12","author":"Shahabipour","year":"2016","journal-title":"Arch. Med. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2024.122743_bb0775","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1039\/D1BM01723C","article-title":"Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3","volume":"10","author":"Liang","year":"2022","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2024.122743_bb0780","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/neuonc\/noac071","article-title":"Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy","volume":"24","author":"Zhan","year":"2022","journal-title":"Neuro-oncology"},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0785","article-title":"Recent electroporation-based systems for intracellular molecule delivery","volume":"4","author":"Dong","year":"2021","journal-title":"Nanotechnology and Precision Engineering (NPE)."},{"key":"10.1016\/j.lfs.2024.122743_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.586130","article-title":"Recent advancements in the loading and modification of therapeutic exosomes","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.lfs.2024.122743_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2020.100261","article-title":"Exosome engineering: current progress in cargo loading and targeted delivery","volume":"20","author":"Fu","year":"2020","journal-title":"NanoImpact"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2024.122743_bb0800","first-page":"61","article-title":"Drug loading techniques for exosome-based drug delivery systems","volume":"76","author":"Xi","year":"2021","journal-title":"Die Pharmazie"},{"issue":"10","key":"10.1016\/j.lfs.2024.122743_bb0805","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/cells12101416","article-title":"Current strategies for exosome cargo loading and targeting delivery","volume":"12","author":"Zeng","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0810","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/neuonc\/nox152","article-title":"Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas","volume":"20","author":"Lang","year":"2018","journal-title":"Neuro-oncology"},{"issue":"8","key":"10.1016\/j.lfs.2024.122743_bb0815","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5483\/BMBRep.2018.51.8.105","article-title":"Exosomes derived from microRNA-584 transfected mesenchymal stem cells: novel alternative therapeutic vehicles for cancer therapy","volume":"51","author":"Kim","year":"2018","journal-title":"BMB Rep."},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0820","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1667\/RR13337.1","article-title":"Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells","volume":"181","author":"Kumar Jella","year":"2014","journal-title":"Radiat. Res."},{"key":"10.1016\/j.lfs.2024.122743_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149425","article-title":"The influence of radiation-induced bystander effect in osteoblasts mediated by plasma-derived extracellular vesicles (EVs)","volume":"695","author":"Du","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2024.122743_bb0830","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/bioengineering9060243","article-title":"The footprint of exosomes in the radiation-induced bystander effects","volume":"9","author":"Jokar","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.lfs.2024.122743_bb0835","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fonc.2019.00869","article-title":"Exosomes in cancer radioresistance","volume":"9","author":"Ni","year":"2019","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122743_bb0840","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.7150\/ijbs.57168","article-title":"Identification of low-dose radiation-induced exosomal circ-METRN and miR-4709-3p\/GRB14\/PDGFR\u03b1 pathway as a key regulatory mechanism in glioblastoma progression and radioresistance: functional validation and clinical theranostic significance","volume":"17","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"21","key":"10.1016\/j.lfs.2024.122743_bb0845","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/onc.2011.436","article-title":"Dynamin 2 mediates PDGFR\u03b1-SHP-2-promoted glioblastoma growth and invasion","volume":"31","author":"Feng","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2024.122743_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111401","article-title":"An indispensable tool: exosomes play a role in therapy for radiation damage","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"90","key":"10.1016\/j.lfs.2024.122743_bb0855","doi-asserted-by":"crossref","first-page":"36083","DOI":"10.18632\/oncotarget.26300","article-title":"Exosomes impact survival to radiation exposure in cell line models of nervous system cancer","volume":"9","author":"Mrowczynski","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0860","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000491774","article-title":"The role of canonical Wnt signaling in regulating radioresistance","volume":"48","author":"Zhao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0865","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260864","article-title":"Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt\/\u03b2-catenin signaling","volume":"16","author":"Wu","year":"2021","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.lfs.2024.122743_bb0870","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ymthe.2019.07.011","article-title":"Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt\/\u03b2-catenin signaling and promotes radiation resistance by targeting TCEAL7","volume":"27","author":"Yue","year":"2019","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2024.122743_bb0875","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/ijms23031353","article-title":"Wnt and PI3K\/Akt\/mTOR survival pathways as therapeutic targets in glioblastoma","volume":"23","author":"Barzegar Behrooz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122743_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2019.151436","article-title":"Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients","volume":"44","author":"Li","year":"2020","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.lfs.2024.122743_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01278-3","article-title":"Exosome-based immunotherapy: a promising approach for cancer treatment","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0890","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40164-022-00289-8","article-title":"Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D\/NKG2D-L pathway to kill CML cells with or without T315I mutation","volume":"11","author":"Du","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2024.122743_bb0895","series-title":"Seminars in Cell & Developmental Biology","article-title":"Exosomes and their roles in immune regulation and cancer","year":"2015"},{"issue":"2","key":"10.1016\/j.lfs.2024.122743_bb0900","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/pharmaceutics15020462","article-title":"Exosomes: the role in tumor tolerance and the potential strategy for tumor therapy","volume":"15","author":"Lv","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0905","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13046-023-02753-7","article-title":"Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts","volume":"42","author":"Khan","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6478","key":"10.1016\/j.lfs.2024.122743_bb0910","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lfs.2024.122743_bb0915","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2017.09.022","article-title":"Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma","volume":"411","author":"Liu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2024.122743_bb0920","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2014.00043","article-title":"Serum microRNAs as biomarkers of human lymphocyte activation in health and disease","volume":"5","author":"de Candia","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-023-00964-w","article-title":"Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments","volume":"30","author":"Nail","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2024.122743_bb0930","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41419-020-03224-z","article-title":"Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells","volume":"11","author":"Guyon","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-021-01492-7","article-title":"Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy","volume":"21","author":"Hosseini","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-023-02996-6","article-title":"Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art","volume":"23","author":"Hatami","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.lfs.2024.122743_bb0945","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41417-021-00352-2","article-title":"Cytokine-enhanced cytolytic activity of exosomes from NK cells","volume":"29","author":"Enomoto","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.lfs.2024.122743_bb0950","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1939601","article-title":"A novel miR1983-TLR7-IFN\u03b2 circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1","volume":"10","author":"Shah","year":"2021","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.lfs.2024.122743_bb0955","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.7150\/thno.18752","article-title":"Exosomes derived from natural killer cells exert therapeutic effect in melanoma","volume":"7","author":"Zhu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2024.122743_bb0960","article-title":"Natural killer cell-derived extracellular vesicles: novel players in cancer immunotherapy","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"issue":"sup3","key":"10.1016\/j.lfs.2024.122743_bb0965","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/21691401.2018.1489824","article-title":"Novel alternatives to extracellular vesicle-based immunotherapy\u2013exosome mimetics derived from natural killer cells","volume":"46","author":"Zhu","year":"2018","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology."},{"issue":"9","key":"10.1016\/j.lfs.2024.122743_bb0970","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.ymthe.2020.06.003","article-title":"Exosomes: a potential therapeutic tool targeting communications between tumor cells and macrophages","volume":"28","author":"Guo","year":"2020","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0975","first-page":"959","article-title":"Preclinical evidence of STAT3 inhibitor pacritinib overcoming temozolomide resistance via downregulating miR-21-enriched exosomes from M2 glioblastoma-associated macrophages. Journal of","volume":"8","author":"Chuang","year":"2019","journal-title":"Clin. Med."},{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0980","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2019.01.076","article-title":"Phenotypic plasticity of invasive edge glioma stem-like cells in response to ionizing radiation","volume":"26","author":"Minata","year":"2019","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.lfs.2024.122743_bb0985","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1158\/2326-6066.CIR-19-0759","article-title":"Transfer of microRNA via macrophage-derived extracellular vesicles promotes proneural-to-mesenchymal transition in glioma stem cells","volume":"8","author":"Zhang","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.lfs.2024.122743_bb0990","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.7150\/thno.82590","article-title":"SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages","volume":"13","author":"Fan","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2024.122743_bb0995","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1073947","article-title":"Tumor-related exosomes contribute to tumor-promoting microenvironment: an immunological perspective","volume":"2017","author":"Chen","year":"2017","journal-title":"Journal of Immunology Research"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524003333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524003333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T01:54:41Z","timestamp":1718675681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524003333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":199,"alternative-id":["S0024320524003333"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122743","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122743"}}